Market Overview

UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Cerner Corporation

Share:
Related CERN
Barron's Picks And Pans: Interpublic, Zimmer Biomet And More
Benzinga's Top Downgrades

In a report published Monday, Sterne Agee Group reiterated its Buy rating on Cerner Corporation (NASDAQ: CERN), and raised its price target from $90.00 to $96.00.

Sterne Agee noted, “We are revising our price target from $90 to $96. This target is based on 14.5x our CY14 EBITDA estimate of $1.1 billion; CERN currently trades at 12x the consensus estimate. The average FY2 EV/EBITDA multiple over the past 10 years is 10x. Our $96 target implies a FY2 P/E multiple of 30x, which is also higher than the 24x CERN has traded at over the past 10 years. We regard CERN as a secular growth stock within the HCIT sector and believe the company can grow earnings in the mid to high teens for the next several years.”

Cerner Corporation closed on Friday at $81.62.

Latest Ratings for CERN

DateFirmActionFromTo
Feb 2016Goldman SachsDowngradesBuyNeutral
Feb 2016Evercore ISI GroupDowngradesBuyHold
Feb 2016UBSMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Sterne Agee GroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (CERN)

View Comments and Join the Discussion!